Maine Revised Statutes, Title 32, § 13841: Authority, 2013

1. Engage in collaborative drug therapy management. A pharmacist licensed in this State who meets the qualifications and requirements of section 13842 and rules adopted by the board may engage in collaborative drug therapy management pursuant to a collaborative practice agreement with a practitioner. [PL 2013, c. 308, §4 (NEW).] 2. Scope of authority. A pharmacist engaging in collaborative drug therapy management pursuant to subsection 1 is entitled to adequate access to a patient's history, disease status, drug therapy and laboratory and procedure results and may: A. Collect and review a patient's history; [PL 2013, c. 308, §4 (NEW).] B. Obtain and check vital signs; [PL 2013, c. 308, §4 (NEW).] C. Order and evaluate the results of laboratory tests directly related to drug therapy under the supervision of, or in direct consultation with, a practitioner and in accordance with approved protocols applicable to the practice setting and when the evaluation does not include a diagnostic component; and [PL 2013, c. 308, §4 (NEW).] D. Initiate, administer, monitor, modify and discontinue drug therapy for a particular patient pursuant to the collaborative practice agreement with a practitioner who is treating the patient, as long as the action is reported to the practitioner in a timely manner as determined by rules adopted pursuant to section 13846. [PL 2021, c. 271, §5 (AMD).] [PL 2021, c. 271, §5 (AMD).]